Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Aurora Cannabis

Cronos Group

Tilray Brands

Cannabis stocks are notching their second day of gains after the Drug Enforcement Administration confirmed it's reviewing an August recommendation from the U.S. Department of Health and Human Services (HHS) to change the classification of marijuana to Schedule III from Schedule I under the Controlled Substances Act. In a letter to Rep.

Cannabis stocks mark second day of gains as DEA confirms its review of marijuana's Schedule I classification

Village Farms International

As the global cannabis industry continues to expand, with its value reaching an impressive $50 billion in 2023, Canadian marijuana stocks are becoming increasingly important to watch in the first quarter of 2024. The early adoption of legalization in Canada has given its companies a significant advantage, allowing them to extend their influence worldwide. This rapid growth and international expansion make Canadian cannabis stocks a focal point for investors in the upcoming quarter.

Investor's Guide: Top Canadian Cannabis Stocks for Q1 2024

Canopy Growth deployed a 1-for-10 reverse stock split in late December. It's the first time the company has had to do so to keep its price above $1.

Why Canopy Growth's Reverse Split Marks a Turning Point for the Business

Canopy Growth just did a reverse stock split. The reverse split won't make generally poor sentiment about the stock any better.

1 Grim Tiding and 2 Silver Linings for Canopy Growth Stock in 2024

A new initiative from the White House injected a much-needed blast of hope throughout the sector. Although the move only affects Americans, it is rightly seen as positive for pot companies in Canada too.

Why Canopy Growth Stock Rocketed 14% Higher Today

Altria

Plug Power

Altria's smokeable products are in decline and they're still a huge part of the company's top line. Plug Power's cash position is dire and more share offerings look to be in the stock's future.

3 Highly Risky Stocks Investors Might Want to Avoid in 2024

AMC Entertainment

Nikola

Certain stocks begin to lose their luster in the ever-evolving world of stock investing, marked by businesses consistently impressing with powerful earnings, cutting-edge technologies, and growing customer bases. This shift positions stocks to sell before 2024, especially as they navigate and sometimes stumble in their corporate journey.

Trim the Fat: 3 Stocks to Exit Before 2023 Wraps Up

Canopy Growth's shareholder-unfriendly 1-for-10 share consolidation took effect yesterday. The company also divested a small subsidiary to hone its focus on the North American cannabis market.

Why Canopy Growth Stock Dropped 13% This Week

Virgin Galactic

SunPower

Despite a strong economy and stock market rally, 2023 saw its fair share of bankruptcy filings. Notable companies ranging from pharmaceutical chain Rite Aid to former gig economy darling WeWork filed for Chapter 11 protection from their creditors over the past year.

Danger Zone: 3 Companies That Could Declare Bankruptcy in 2024

Canopy Growth (NASDAQ: CGC) stock price had a tough performance in 2023. It started the year well as it peaked at $32.18 in February before diving to the year-to-date low of $3.43.

Canopy Growth: What next for the vulnerable CGC stock?

Marijuana company Canopy Growth (NYSE: CGC ) fell 3.6% overnight after completing a 1-for-10 reverse stock split. However, CGC stock has recouped those losses in early trading and is now up about 4%.

Canopy Growth Just Enacted a 1-for-10 Reverse Split of CGC Stock

Canopy Growth's strategy revolves around the U.S. cannabis market and the possibility of legalization. Tilray Brands has been expanding into other parts of the world and diversifying its business.

Better Growth Stock: Canopy Growth vs. Tilray Brands

There is much anticipation about how marijuana stocks will trade during 2024. There is a lot in the works that stands a good chance to help the sector trade up. In 2024 we will see a continued effort to establish better laws and regulations. Currently, politicians are fighting to pass some type of federal reform. Yet cannabis banking is legislation that would help the cannabis industry greatly. This is due to the industry primarily dealing only in cash as cannabis is still federally illegal.

Top Canadian Marijuana Stocks In The Stocks Market Today

Divestiture of the skincare and wellness brand is aligned with Canopy Growth's focus on North American cannabis operations SMITHS FALLS, ON and LONDON , Dec. 18, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today announced that the Company has completed the divestiture of its This Works skincare and wellness brand to Inspirit Capital, a London-based investment firm. Headquartered in London, England, This Works offers a range of high-quality natural skincare and sleep solution products to consumers around the world.

Canopy Growth Announces Completed Sale of This Works

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

In 2023, the cannabis industry and top marijuana stocks are at a crucial point of growth and transformation. As legal restrictions ease and societal acceptance increases, the sector is experiencing unprecedented expansion. This article offers a comprehensive overview of the industry's current state, future growth prospects, US policy implications, leading companies, and investment strategies.

The Cannabis Sector in 2023: Growth Prospects and Market Dynamics

Canopy Growth announced it will implement a 1-for-10 reverse stock split next week to remain compliant with Nasdaq's $1-per-share listing requirements. Shareholders will not be paid for any fractional shares stemming from the consolidation.

Why Canopy Growth Stock Plunged 35% This Week

AdvisorShares Pure US Cannabis ETF

Cannabis stocks might be approaching the end of their hard times. In Canada, a couple of companies are getting close to generating positive cash flow.

2024 Could Be the Year of the Cannabis Stock Comeback. Here's How to Invest.

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) shares plunged more than 20% after the cannabis company said it would be conducting a 1 for 10 consolidation of its shares to regain compliance with the Nasdaq minimum bid price. The consolidation was approved by the company's shareholders at its annual general and special meeting of shareholders held on September 25, 2023, Canopy Growth said.

Canopy Growth stock plummets on share consolidation plan

Marijuana grower Canopy Growth (NYSE: CGC ) will go through a 1-for-10 reverse stock split on Dec. 15. Management called this a “share consolidation.

Why Is Canopy Growth (CGC) Stock Down 25% Today?

Canopy Growth announced that its 10-for-1 reverse stock split is on track to take effect on Dec. 20. But the upcoming capital restructuring will be done in a way that investors aren't happy about.

Why Canopy Growth Stock Is Getting Smoked Today

Shares will be consolidated at a 1 for 10 ratio Action expected to allow the Company to regain compliance with Nasdaq minimum bid price requirement SMITHS FALLS, ON , Dec. 13, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) announced today that the Company's board of directors has approved the consolidation (the "Consolidation") of the Company's issued and outstanding common shares (the "Common Shares") on the basis of one (1) post-Consolidation Common Share for every ten (10) pre-Consolidation Common Shares. The Consolidation is being implemented to ensure that the Company continues to comply with the listing requirements of the Nasdaq Global Select Market (the "Nasdaq").

Canopy Growth Announces Effective Date of Share Consolidation

OrganiGram Holdings Inc.

SNDL Inc.

Are marijuana stock investors using volatility to their advantage? As most know the cannabis sector is a place where most of the pot stocks trade with inconsistent patterns. Now to elaborate most companies trade with patterns that often show major volatility. This is what makes it tough to identify when it is time to buy or sell. To be more descriptive when there is a jump in trading you do not know how long it will last.

3 Canadian Marijuana Stocks To Watch Today

Canopy Growth is one of the top cannabis producers in Canada, but the business has been struggling. It recently sold off a cash-burning business in BioSteel in an effort to become leaner.

Down 74% This Year, Canopy Growth Stock Isn't in Good Shape for Cannabis Investors Heading Into 2024

Canopy Growth gets 12% of its total sales from Germany. The country delayed a vote on marijuana legalization late on Monday.

Why Canopy Growth Stock Crashed 11% on Tuesday

As December 2023 arrives, Canadian cannabis stocks are increasingly capturing the attention of investors worldwide. The global cannabis industry has been on a steady rise, with projections indicating a significant expansion in market value. This growth is fueled by increasing legalization and societal acceptance. In Canada, a pioneer in legalizing cannabis, companies are well-positioned to capitalize on this trend. Short-term traders and long-term investors find these stocks appealing, each with distinct strategies and goals.

News for Canopy Growth Stock (CGC)